Ascendis Pharma A/S
ASND
$195.98
$0.010.01%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
8/12/2025
-
MarketBeat
8/11/2025
-
MarketBeat
8/11/2025
-
MarketBeat
8/11/2025
-
MarketBeat
8/10/2025
-
MarketBeat
8/10/2025
-
MarketBeat
8/10/2025
-
Ticker Report
8/10/2025
-
MarketBeat
8/9/2025
-
MarketBeat
8/9/2025
-
MarketBeat
8/9/2025
-
MarketBeat
8/9/2025
-
MarketBeat
8/9/2025
-
MarketBeat
8/9/2025
-
SeekingAlpha
8/9/2025
-
Seeking Alpha: Transcripts
8/8/2025
-
MarketBeat
8/8/2025
-
Tickeron - Stocks
8/8/2025
-
GuruFocus
8/7/2025
-
GuruFocus
8/7/2025
-
Globe Newswire
8/7/2025
-
ETF Channel
8/7/2025
-
Tickeron - Technical Analysis
8/6/2025
-
MarketBeat
8/5/2025
-
MarketBeat
Income Statement
Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Thursday, August 7, 2025
Period Date
Monday, June 30, 2025
Next Filing
Week of Nov 10 and 14 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
45 70 22 22 44
Address
Tuborg Boulevard 12
Hellerup, 2900
Hellerup, 2900
Country
Year Founded
Business Description
Sector
--
Industry
--
Ascendis Pharma A/S, operates as a biopharmaceutical company that focuses on developing TransCon-based therapies for unmet medical needs in Denmark, rest of Europe, North America, and...
more